Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Feb 16, 2021 FORM 4 SUBMISSION
4 Feb 16, 2021 FORM 4 SUBMISSION
4 Feb 16, 2021 FORM 4 SUBMISSION
SC 13G/A Feb 16, 2021 SC 13G/A
SC 13G/A Feb 12, 2021 SC 13G/A
SC 13G/A Feb 11, 2021
8-K Jan 11, 2021 8-K
4 Dec 23, 2020 FORM 4 SUBMISSION
3 Dec 23, 2020 FORM 3 SUBMISSION
8-K Dec 23, 2020 8-K
CT ORDER Dec 21, 2020
8-K Nov 9, 2020 8-K
10-Q Nov 5, 2020 10-Q
8-K Nov 5, 2020 8-K
4 Nov 4, 2020 FORM 4 SUBMISSION
3 Nov 4, 2020 FORM 3 SUBMISSION
3 Oct 13, 2020 FORM 3 SUBMISSION
8-K Oct 2, 2020 8-K
4 Sep 16, 2020 FORM 4 SUBMISSION
3 Sep 16, 2020 FORM 3 SUBMISSION
8-K Sep 2, 2020 8-K
10-Q Aug 6, 2020 10-Q
8-K Aug 6, 2020 8-K
SC 13D Jul 14, 2020 ACQUISITION OF BENEFICIAL OWNERSHIP
3 Jul 13, 2020 FORM 3 SUBMISSION
← Newer Page 19 of 27 · 661 filings Older →